Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms

American Journal of Pathology

Volumn 182, Issue 1, 2013, Pages 234-243

  Zolk, Oliver ^a   Schnepf, Rebecca ^a   Muschler, Marc ^b   Fromm, Martin F ^a   Wendler, Olaf ^a   Traxdorf, Maximilian ^a   Iro, Heinrich ^a   Zenk, Johannes ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ABCC3 PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; ORGANIC ANION TRANSPORTER 1; PREGNANE X RECEPTOR; SLCO1B3 PROTEIN; SLCO2A1 PROTEIN; SLCO2B1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC ASSOCIATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, STEROID; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84871322017     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.09.008     Document Type: Article

References (43)

1. Y. Huang Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy Cancer Metastasis Rev 26 2007 183 201 (Pubitemid 46452190)
2. O. Zolk Disposition of metformin: variability due to polymorphisms of organic cation transporters Ann Med 44 2012 119 129
3. G. Szakacs, J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, and M.M. Gottesman Targeting multidrug resistance in cancer Nat Rev Drug Discov 5 2006 219 234 (Pubitemid 43336035)
4. T.F. Solbach, J. König, M.F. Fromm, and O. Zolk ATP-binding cassette transporters in the heart Trends Cardiovasc Med 16 2006 7 15 (Pubitemid 43012035)
5. C. Fahrmayr, M.F. Fromm, and J. König Hepatic OATP and OCT uptake transporters: their role for drug-drug interactions and pharmacogenetic aspects Drug Metab Rev 42 2010 380 401
6. J. König, A. Seithel, U. Gradhand, and M.F. Fromm Pharmacogenomics of human OATP transporters Naunyn Schmiedebergs Arch Pharmacol 372 2006 432 443
7. B. Hagenbuch, and C. Gui Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family Xenobiotica 38 2008 778 801
8. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
9. D.J. Stewart, J.P. Issa, R. Kurzrock, M.I. Nunez, J. Jelinek, D. Hong, Y. Oki, Z. Guo, S. Gupta, and I.I. Wistuba Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas Clin Cancer Res 15 2009 3881 3888
10. P.C. Taberlay, and P.A. Jones DNA methylation and cancer Prog Drug Res 67 2011 1 23
11. E.E. Bram, M. Stark, S. Raz, and Y.G. Assaraf Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance Neoplasia 11 2009 1359 1370
12. K.L. Bennett, M. Karpenko, M.T. Lin, R. Claus, K. Arab, G. Dyckhoff, P. Plinkert, E. Herpel, D. Smiraglia, and C. Plass Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma Cancer Res 68 2008 4494 4499
13. R.G. Tirona Molecular mechanisms of drug transporter regulation Handb Exp Pharmacol 201 2011 373 402
14. S. Harmsen, I. Meijerman, C.L. Febus, R.F. Maas-Bakker, J.H. Beijnen, and J.H. Schellens PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line Cancer Chemother Pharmacol 66 2010 765 771
15. H. Masuyama, N. Suwaki, Y. Tateishi, H. Nakatsukasa, T. Segawa, and Y. Hiramatsu The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion Mol Endocrinol 19 2005 1170 1180 (Pubitemid 40594117)
16. W. Habano, T. Gamo, J. Terashima, T. Sugai, K. Otsuka, G. Wakabayashi, and S. Ozawa Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells BMC Cancer 11 2011 81
17. A. Misawa, J. Inoue, Y. Sugino, H. Hosoi, T. Sugimoto, F. Hosoda, M. Ohki, I. Imoto, and J. Inazawa Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification Cancer Res 65 2005 10233 10242 (Pubitemid 41743715)
18. C.J. Krause, T.E. Carey, R.W. Ott, C. Hurbis, K.D. McClatchey, and J.A. Regezi Human squamous cell carcinoma: establishment and characterization of new permanent cell lines Arch Otolaryngol 107 1981 703 710 (Pubitemid 11027726)
19. J.C. Brenner, M.P. Graham, B. Kumar, L.M. Saunders, R. Kupfer, R.H. Lyons, C.R. Bradford, and T.E. Carey Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines Head Neck 32 2010 417 426
20. M. Zhao, D. Sano, C.R. Pickering, S.A. Jasser, Y.C. Henderson, G.L. Clayman, E.M. Sturgis, T.J. Ow, R. Lotan, T.E. Carey, P.G. Sacks, J.R. Grandis, D. Sidransky, N.E. Heldin, and J.N. Myers Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites Clin Cancer Res 17 2011 7248 7264
21. F. Eckhardt, J. Lewin, R. Cortese, V.K. Rakyan, J. Attwood, M. Burger, J. Burton, T.V. Cox, R. Davies, T.A. Down, C. Haefliger, R. Horton, K. Howe, D.K. Jackson, J. Kunde, C. Koenig, J. Liddle, D. Niblett, T. Otto, R. Pettett, S. Seemann, C. Thompson, T. West, J. Rogers, A. Olek, K. Berlin, and S. Beck DNA methylation profiling of human chromosomes 6, 20 and 22 Nat Genet 38 2006 1378 1385 (Pubitemid 44837559)
22. J. Lewin, A.O. Schmitt, P. Adorjan, T. Hildmann, and C. Piepenbrock Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates Bioinformatics 20 2004 3005 3012 (Pubitemid 39619192)
23. B. Stefanska, J. Huang, B. Bhattacharyya, M. Suderman, M. Hallett, Z.G. Han, and M. Szyf Definition of the landscape of promoter DNA hypomethylation in liver cancer Cancer Res 71 2011 5891 5903
24. W. Lee, A. Belkhiri, A.C. Lockhart, N. Merchant, H. Glaeser, E.I. Harris, M.K. Washington, E.M. Brunt, A. Zaika, R.B. Kim, and W. El-Rifai Overexpression of OATP1B3 confers apoptotic resistance in colon cancer Cancer Res 68 2008 10315 10323
25. V.R. Holla, M.G. Backlund, P. Yang, R.A. Newman, and R.N. DuBois Regulation of prostaglandin transporters in colorectal neoplasia Cancer Prev Res (Phila) 1 2008 93 99
26. H. Pressler, T.M. Sissung, D. Venzon, D.K. Price, and W.D. Figg Expression of OATP family members in hormone-related cancers: potential markers of progression PLoS One 6 2011 e20372
27. M. Yang, W. Xie, E. Mostaghel, M. Nakabayashi, L. Werner, T. Sun, M. Pomerantz, M. Freedman, R. Ross, M. Regan, N. Sharifi, W.D. Figg, S. Balk, M. Brown, M.E. Taplin, W.K. Oh, G.S. Lee, and P.W. Kantoff SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer J Clin Oncol 29 2011 2565 2573
28. J.L. Wright, E.M. Kwon, E.A. Ostrander, R.B. Montgomery, D.W. Lin, R. Vessella, J.L. Stanford, and E.A. Mostaghel Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes Cancer Epidemiol Biomarkers Prev 20 2011 619 627
29. W. Al Sarakbi, R. Mokbel, M. Salhab, W.G. Jiang, M.J. Reed, and K. Mokbel The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer Anticancer Res 26 2006 4985 4990 (Pubitemid 46032147)
30. S. Furness, A.M. Glenny, H.V. Worthington, S. Pavitt, R. Oliver, J.E. Clarkson, M. Macluskey, K.K. Chan, and D.I. Conway Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy Cochrane Database Syst Rev 4 2011 CD006386
31. C.M. Anderson, and D.T. Thwaites Hijacking solute carriers for proton-coupled drug transport Physiology (Bethesda) 25 2010 364 377
32. S. Tsunoda, T. Okumura, T. Ito, K. Kondo, C. Ortiz, E. Tanaka, G. Watanabe, A. Itami, Y. Sakai, and Y. Shimada ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma Oncology 71 2006 251 258
33. S. Ichihara, R. Kikuchi, H. Kusuhara, S. Imai, K. Maeda, and Y. Sugiyama DNA methylation profiles of organic anion transporting polypeptide 1B3 in cancer cell lines Pharm Res 27 2010 510 516
34. K.K. To, Z. Zhan, and S.E. Bates Aberrant promoter methylation of the ABCG2 gene in renal carcinoma Mol Cell Biol 26 2006 8572 8585 (Pubitemid 44748589)
35. R. Abele, M. Clavel, P. Dodion, U. Bruntsch, S. Gundersen, J. Smyth, J. Renard, M. van Glabbeke, and H.M. Pinedo The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2′-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas Eur J Cancer Clin Oncol 23 1987 1921 1924 (Pubitemid 18013335)
36. J. Kim, J. Guan, I. Chang, X. Chen, D. Han, and C.Y. Wang PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells Mol Cancer Ther 9 2010 1977 1984
37. M.B. Prystowsky, A. Adomako, R.V. Smith, N. Kawachi, W. McKimpson, P. Atadja, Q. Chen, N.F. Schlecht, J.L. Parish, G. Childs, and T.J. Belbin The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines J Pathol 218 2009 467 477
38. S.W. Dong, P. Zhang, Y.M. Liu, Y.T. Cui, S. Wang, S.J. Liang, Z. He, P. Sun, and Y.G. Wang Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma World J Gastroenterol 18 2012 576 582
39. N. Hanada, T. Takahata, Q. Zhou, X. Ye, R. Sun, J. Itoh, A. Ishiguro, H. Kijima, J. Mimura, K. Itoh, S. Fukuda, and Y. Saijo Methylation of the KEAP1 gene promoter region in human colorectal cancer BMC Cancer 12 2012 66
40. A. Geick, M. Eichelbaum, and O. Burk Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin J Biol Chem 276 2001 14581 14587
41. X. Cheng, J. Maher, M.Z. Dieter, and C.D. Klaassen Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways Drug Metab Dispos 33 2005 1276 1282 (Pubitemid 41196968)
42. T.W. Synold, I. Dussault, and B.M. Forman The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux Nat Med 7 2001 584 590 (Pubitemid 32448326)
43. S. Harmsen, I. Meijerman, J.H. Beijnen, and J.H. Schellens The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology Cancer Treat Rev 33 2007 369 380 (Pubitemid 46760528)